Vault-13

LANDOS BIOPHARMA INC

COM · CUSIP 515069102

0 institutional holders -21 vs Q1 2023
—reported value*
0 new 0 added 0 reduced 21 sold out net sold ≈ $4.6m (-15.5m shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.

Trends to Q2 2023

Institutional holders

Managers reporting a position, each quarter

02040Q3 22: 32Q4 22: 24Q1 23: 21Q2 23: 00Q3 22Q4 22Q1 23Q2 23
Numbers
QuarterHolders
Q3 202232
Q4 202224
Q1 202321
Q2 20230

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
40040Q4 22: 9 bought or addedQ4 22: 19 cut or sold outQ4 22Q1 23: 7 bought or addedQ1 23: 13 cut or sold outQ1 23Q2 23: 0 bought or addedQ2 23: 21 cut or sold outQ2 23
Numbers
QuarterBought or addedCut or sold out
Q4 2022919
Q1 2023713
Q2 2023021

Biggest buyers

None

Biggest sellers

PERCEPTIVE ADVISORS LLC Sold out -14,869,915-14.9m
MACQUARIE GROUP LTD Sold out -147,182-147.2k
GEODE CAPITAL MANAGEMENT, LLC Sold out -91,538-91.5k
CITADEL ADVISORS LLC Sold out -86,093-86.1k
RENAISSANCE TECHNOLOGIES LLC Sold out -79,201-79.2k
Warberg Asset Management LLC Sold out -73,504-73.5k
BRIDGEWAY CAPITAL MANAGEMENT, LLC Sold out -39,000-39.0k
BlackRock Inc. Sold out -33,815-33.8k
STATE STREET CORP Sold out -25,200-25.2k
VANGUARD GROUP INC Sold out -23,995-24.0k

Holders, Q2 2023

#ManagerLocationShares Value% of their portfolioChangeShares change